结核病治疗结果和相关因素在贝纳迪尔索马里. 一个多中心的队列研究
Mevlüt Karataş1, Abdirahman Mohamed Hassan Dirie1, Sedat Çolakoğlu1
1Pulmonology Department, Somalia Mogadishu Türkiye Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Benadir, Somalia.
International journal of general medicine
|June 19, 2024
概括
索马里贝纳迪尔的结核病治疗成功率为80.6%,低于全球目标. 高龄和艾滋病毒同时感染与较差的结局有关,突出显示需要改善结核病服务.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,特别是在索马里等资源较低的环境中.
- 了解区域治疗结果对于有效的结核病控制策略至关重要.
研究的目的:
- 评估索马里贝纳迪尔结核病患者的治疗结果.
- 确定与治疗成功和失败相关的因素.
主要方法:
- 一项回顾性队列研究分析了2019年7月至2020年6月期间接受治疗的3165名结核病患者的数据.
- 治疗结果 (成功,失败,丢失,死亡,转移) 被评估.
- 奇平方测试确定了与治疗结果相关的因素.
主要成果:
- 结核病治疗总体成功率为80.6%,低于全球90%的目标.
- 不利的结果包括5.3%的随访失踪,4.6%的死亡和4.6%的转移.
- 高龄和艾滋病毒同时感染与较差的治疗结果有关.
结论:
- 贝纳迪尔的结核病治疗成功率低于最佳,需要有针对性的干预措施.
- 改善获得优质结核病诊断和治疗服务的机会至关重要.
- 解决社会经济障碍对于提高治疗坚持和结核病控制至关重要.
相关概念视频
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis I
231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III
321
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
321
Pulmonary Tuberculosis II
217
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217
Pneumonia IV: Management
319
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
319


